News and References
All the links on this page go to abstracts of articles. All the full versions are available at the Centre for Interventional Psychiatry. You can also view or buy them on the publisher’s website.
INTERVENTIONAL PSYCHIATRY IN SWITZERLAND
Swiss Society of Interventional Psychiatry (SSIP)
Other specialists in Switzerland
- Geneva: Dr Fady Rachid (TMS)
- Zürich: Dr Michael Fischer (TMS and other techniques)
NITROUS OXIDE FOR DEPRESSION
Nitrous oxide for the treatment of psychiatric disorders: A systematic review of the clinical trial landscape. (Acta Psychiatr Scand)
The evolution of NMDA receptor antagonists as antidepressant agents. (J Neurol Sci).
Nitrous Oxide Reduced Suicidal Ideation in Treatment-Resistant Major Depression in Exploratory Analysis. (J Clin Psychiatry)
The efficacy and tolerability of inhaled nitrous oxide in major depressive disorder: a systematic review and meta‑analysis. (Psychopharmacology (Berl))
Mini-Review: A Brief History of Nitrous Oxide (N2O) Use in Neuropsychiatry. (Curr Drug Res Rev.)
Exploring Nitrous Oxide as Treatment of Mood Disorders: Basic Concepts. (J Clin Psychopharmacol)
Nitrous Oxide: an emerging novel treatment for treatment-resistant depression. (J Neurol Sci. 2022 Mar 15;434:120092)
Safety and efficacy of an equimolar mixture of oxygen and nitrous oxide: a randomized controlled trial in patients with peripheral neuropathic pain. (Pain)
A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression. (Sci Transl Med.)
Laughing gas shows promise for treatment-resistant depression, small trial finds. (nbcnews.com)
Low doses of ‘laughing gas’ could be effective in treating severe depression. (news.uchicago.edu)
Nitrous Oxide (“Laughing Gas”) May Have Rapid-Acting Anti-Suicidal Effects. (The Brain & Behavior Research Foundation)
GENERAL INFORMATION ON TMS
EFFICIENCY AND SAFETY OF TMS
Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines. (Clinical Neurophysiology)
TMS EFFICIENCY FOR DEPRESSION
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. (Biological Psychiatry)
Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression: a network meta-analysis of randomized controlled trials. (Journal of Affective Disorders)
Transcranial magnetic stimulation for geriatric depression: Promises and pitfalls (World Journal of Psychiatry)
Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again. (Australian & New Zealand Journal of Psychiatry)
TMS EFFICIENCY FOR OTHER INDICATIONS
Transcranial magnetic stimulation of dorsolateral prefrontal cortex reduces cocaine use: A pilot study (European Neuropsychopharmacology)
Repetitive transcranial magnetic stimulation in chronic pain: a review of the literature. (Archives of Physical Medicine and Rehabilitation)
Long-term maintenance of the analgesic effects of transcranial magnetic stimulation in fibromyalgia. (Pain)
Review of the effectiveness of transcranial magnetic stimulation for post-traumatic stress disorder. (Brain Stimulation)
An Update of the Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients with Obsessive Compulsive Disorder. (Neuropsychiatry)
Repetitive transcranial magnetic stimulation for obsessive-compulsive disorder: A systematic review and pairwise/network meta-analysis. (Journal of Affective Disorders)
A pilot study of fMRI targeted rTMS for obsessive compulsive disorder. (Brain Stimulation)
Repetitive Transcranial Magnetic Stimulation Treatment for Chronic Tinnitus: A Randomized Clinical Trial. (JAMA Otolaryngoloy – head & Neck Surgery)
Repetitive Transcranial Magnetic Stimulation for Phantom Limb Pain in Land Mine Victims: A Double-Blinded, Randomized, Sham-Controlled Trial. (Journal of Pain)
Brain Stimulation in Alzheimer’s Disease. (Frontiers in Psychiatry)
Repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease. (Neurophysiologie clinique)
Neuromodulation for the treatment of eating disorders and obesity. (Therapeutic Advances in Psychopharmacology)
ECT EFFICIENCY FOR DEPRESSION
Relapse Following Successful Electroconvulsive Therapy For Major Depression: A Meta- Analysis. (Neuropsychopharmacology)
Maintenance electroconvulsive therapy up to 12 years. (Journal of Affective Disorders)
Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication. (The British Journal of Psychiatry)
Electroconvulsive Therapy in the Elderly: New Findings in Geriatric Depression. (Current psychiatry reports)
Improvements in Health-Related Quality of Life With Electroconvulsive Therapy – A Meta-analysis. (The Journal of ECT)
ECT FOR BIPOLAR DISORDER
Electroconvulsive therapy in bipolar depression – effectiveness and prognostic factors Treatment. (Acta Psychiatrica Scandinavica)
What happens to the course of bipolar disorder after electroconvulsive therapy? (Journal of Affective Disorders)
ECT FOR SCHIZOPHRENIA
Electroconvulsive Therapy and Schizophrenia – A Systematic Review (Molecular Neuropsychiatry)
Augmentation of Antipsychotics with Electroconvulsive Therapy in Treatment-Resistant Schizophrenia Patients with Dominant Negative Symptoms: A Pilot Study of Effectiveness. (Neuropsychobiology)
Electroconvulsive therapy in ultra-resistant schizophrenia – A case series. (Asian Journal of Psychiatry)
Clinical Effectiveness of Maintenance Electroconvulsive Therapy in Patients with Schizophrenia: A retrospective Cohort Study (Journal of ECT)
AUDIO & VIDEO
The Psychedelic Revolution – Don’t Forget About Ketamine
TMS en psychiatrie – AP-HM mag flash, Assistance Publique-Hôpitaux de Marseille
TMS Brain Stimulation Can Help Combat Depression, Beth Israel Deaconess Medical Center, Boston
Ketamine for Treatment-Refractory Depression – Video Interview with James Murrough, MD
Des électrochocs contre la dépression. Emission 36,9° du 10.05.2017, RTS1
L’électricité pour lutter contre la dépression. Emission CQFD du 30.08.2018, RTS La 1ère
Dépression, de l’ombre à la lumière. Emission Temps Présent du 06.12.2018, RTS1
TRANSCRANIAL PULSE STIMULATION
Transcranial Pulse Stimulation (TPS) – a treatment option for patients with Alzheimer’s disease
Transcranial pulse stimulation (TPS) improves depression in AD patients on state-of-the-art treatment. (Alzheimers Dement (N Y))
Transcranial pulse stimulation in Alzheimer’s disease. (CNS Neurosci Ther.)
Transcranial ultrasound pulse stimulation reduces cortical atrophy in Alzheimer’s patients: A follow-up study. (Alzheimer’s Dement.)
Retrospective real-world pilot data on transcranial pulse stimulation in mild to severe Alzheimer’s patients. (Front Neurol.)
Transcranial pulse stimulation in the treatment of mild neurocognitive disorders. (Ann Clin Transl Neurol.)
KETAMINE FOR DEPRESSION
A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. (American Journal of Psychiatry)
Low-dose ketamine for treatment resistant depression in an academic clinical practice setting. (journal of affective disorders)
Kétamine comme option thérapeutique (Swiss Medical Forum)
How club drug ketamine fights depression (Nature)
Rave drug holds promise for treating depression fast (Nature)
ketamine: stimulating antidepressant treatment? (British Journal of Psychiatry)
Ketamine for treatment-resistant depression: recent developments and clinical applications. (British Medical Journal)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites. (Nature)
Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion. (Journal of Affective Disorders)
Administration of ketamine for unipolar and bipolar depression. (International Journal of Psychiatry in Clinical Practice)
Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity. (Journal of Psychopharmacology)
Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.(Journal of Affective Disorders)
KETAMINE FOR OTHER INDICATIONS
Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder – proof-of-concept. (Neuropsychopharmacology)
Rapid Resolution of Obsessions After an Infusion of Intravenous Ketamine in a Patient with Treatment-Resistant Obsessive-Compulsive Disorder – A Case Report. (Journal of Clinical Psychiatry)
Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders. (Journal of Psychopharmacology)
Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. (JAMA Psychiatry)
ECT: SECURITY, MECHANISMS AND SIDE EFFECTS
Neuropathological evaluation of an 84-year-old man after 422 ECT treatments. (Journal of ECT)
Electroconvulsive therapy increases temporal gray matter volume and cortical thickness. (European Neuropsychopharmacology)
Objective Cognitive Performance Associated with Electroconvulsive Therapy for Depression: A Systematic Review and Meta-Analysis. (Biological Psychiatry)
Evaluation of cumulative cognitive deficits from electroconvulsive therapy. (British Journal of Psychiatry).
An Examination of Mortality and Other Adverse Events Related to Electroconvulsive Therapy Using a National Adverse Event Report System. (Journal of ECT)
Neurotransmitters and Electroconvulsive Therapy. (Journal of ECT)
Hippocampal Neurogenesis and Antidepressive Therapy: Shocking Relations. (Neural Plasticity)
Grey matter volume increase following electroconvulsive therapy in patients with late life depression: a longitudinal MRI study. (Journal of Psychiatry & Neuroscience)
Effect of electroconvulsive therapy on gray matter volume in major depressive disorder. (Journal of Affective Disorders)
Mechanisms of Antidepressant Response to Electroconvulsive Therapy Studied With Perfusion Magnetic Resonance Imaging. (Biological Psychiatry)
Neuromodulation in response to electroconvulsive therapy in schizophrenia and major depression. (Brain Stimulation)
Long-Term Cognitive and Psychological Functioning in Post–Electroconvulsive Therapy Patients. (Journal of ECT)
Electroconvulsive therapy and risk of dementia in patients with affective disorders – a cohort study. (Lancet Psychiatry)
ECT: An essential therapy in psychiatry. (L’Encéphale)
OTHER USEFUL RESOURCES